Macrophages in multiple myeloma

Domenico Ribatti1, Michele Moschetta2, Angelo Vacca2

  • 1Department of Basic Medical Sciences, Neurosciences and Sensory Organs, University of Bari Medical School, Bari, Italy; National Cancer Institute "Giovanni Paolo II", Bari, Italy.

Immunology Letters
|December 28, 2013
PubMed

Insights

Tumor associated macrophages (TAMs) promote tumor growth and vascularization by releasing growth factors. Inhibiting macrophage recruitment may offer a new therapeutic strategy for multiple myeloma.

Area of Science:

  • Oncology
  • Immunology
  • Hematology

Background:

  • Tumor-associated macrophages (TAMs) are key players in tumor microenvironments.
  • TAMs secrete pro-angiogenic factors that support tumor growth and vascularization.
  • Previous studies show a link between TAMs, tumor growth rate, and vascularization in various cancers.

Purpose of the Study:

  • To summarize existing literature and present new data on the role of TAMs in multiple myeloma angiogenesis.
  • To discuss potential therapeutic strategies targeting macrophage recruitment in multiple myeloma.

Main Methods:

  • Literature review of TAMs and angiogenesis in multiple myeloma.
  • Analysis of experimental data concerning TAMs in multiple myeloma models.
  • Discussion of therapeutic agents targeting macrophage recruitment.

Main Results:

  • TAMs are a significant source of pro-angiogenic cytokines and growth factors in multiple myeloma.
  • A correlation exists between TAM content, tumor growth rate, and vascularization in multiple myeloma.
  • Inhibiting macrophage recruitment presents a potential therapeutic avenue.

Conclusions:

  • TAMs play a crucial role in promoting angiogenesis and tumor progression in multiple myeloma.
  • Targeting macrophage recruitment offers a promising therapeutic strategy for multiple myeloma treatment.

Related Concept Videos